Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008

Transfusion

Volumn 55, Issue 3, 2015, Pages 636-646

  Lafeuillade, Bruno ^a   Eb, François ^a   Ounnoughene, Nadra ^a   Petermann, Rachel ^a   Daurat, Gérald ^a   Huyghe, Gérard ^a   Vo Mai, Mai Phuong ^a   Caldani, Cyril ^a   Rebibo, Danielle ^a   Weinbreck, Pierre ^a  

^a AFSSAPS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; BLOOD BANK; BLOOD COMPONENT; BLOOD SAFETY; BLOOD TRANSFUSION REACTION; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FATALITY; FEMALE; FRANCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MIDDLE AGED; PLASMA TRANSFUSION; RETROSPECTIVE STUDY; SKIN FLORA; THROMBOCYTE TRANSFUSION; TRANSFUSION TRANSMITTED BACTERIAL INFECTION; ADVERSE EFFECTS; BACTEREMIA; BLOOD; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; LEUKAPHERESIS; MANDATORY REPORTING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHLEBOTOMY; PROCEDURES; RISK; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SYMPTOM ASSESSMENT; TRANSMISSION;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; FRANCE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LEUKOCYTE REDUCTION PROCEDURES; MANDATORY REPORTING; PHLEBOTOMY; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT;

EID: 84924514446     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12883     Document Type: Article

References (56)

1. Blajchman MA, Goldman M, Baeza F,. Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004; 18: 11-24.
2. Brecher ME, Hay SN,. Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18: 195-204.
3. de Vries RR, Faber JC, Strengers PF,. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang 2011; 100: 60-67.
4. Loi n°93-5 du 4 janvier 1993 relative à la sécurité en matière de transfusion sanguine et du médicament. J O Repub Fr 1993 Jan 1:237-46.
5. Morel P, Herve P,. Surveillance of blood transfusion safety: contribution of the hemovigilance strategy in France. Transfus Med Rev 1998; 12: 109-127.
6. Gulian C, Arnold J, Jacq S, et-al. Guide d'hygiène de l'EFS à l'usage de ses établissements version 01. January 2000.
7. Décret n°2006-99 du 1er février 2006 relatif à l'Etablissement français du sang et à l'hémovigilance et modifiant le code de la santé publique (dispositions réglementaires). J O Repub Fr 2006 Feb 3: text 22/136.
8. Delbosc A, Lafeuillade B, Petermann R, et-al. Transfusion transmitted bacterial infections (TTBI) with blood component accountability score 2: retrospective analysis of the French e-fit database 2000-2007. Transfus Clin Biol 2011; 18: 26-35.
9. Circulaire DGS/DHOS/AFSSAPS n° 2003-581 du 15 décembre 2003 relative aux recommandations concernant la conduite à tenir en cas de suspicion d'incident transfusionnel par contamination bactérienne. [cited 2014 Sep 14]. Available from http://www.sante.gouv.fr/fichiers/bo/2004/04-02/a0020108.htm
10. Quaranta JF, Bethier F, Courbil R, et-al. Who uses blood ? Results of a cross-sectional and nation wide survey. Transfus Clin Biol 2009; 16: 21-29.
11. Leclercq A, Martin L, Laporte Vergnes M, et-al. Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion. From the Pasteur Institute, National Reference Laboratory and WHO Collaborating Center for Yersinia, Paris, France. Transfusion 2005; 45: 814-818.
12. Rao PL, Strausbaugh LJ, Liedtke LA, et-al. Bacterial infections associated with blood transfusion: experience and perspective of infection diseases consultants. Transfusion 2007; 47: 1206-1211.
13. Faber JC,. Review of main hemovigilance systems in the world. Transfus Clin Biol 2009; 16: 86-92.
14. Yomtovian R,. Bacterial contamination of blood: lessons from the past and road map for the future. Transfusion 2004; 44: 450-460.
15. Traore AN, Delage G, McCombie N, et-al. Clinical and laboratory practices in investigation of suspected transfusion-transmitted bacterial infection: a survey of Canadian hospitals. Vox Sang 2009; 96: 157-159.
16. Rapport d'activité d'hémovigilance 2011. July 2012. [cited 2014 Sep 14]. Available from http://ansm.sante.fr/var/ansm-site/storage/original/application/94eaed87fcb1d3c9d2187f4945256875.pdf
17. Perez P, Salmi LR, Follea G, et-al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-control study. Transfusion 2001; 41: 862-872.
18. Serious Hazard of Transfusion. The SHOT Annual Reports. Annual reports from 2000 to 2012. [cited 2014 Sep 14]. Available from http://www.shotuk.org/shot-reports/
19. Keller-Stanislawski B, Lohmann A, Günay S, et-al. The German Haemovigilance System-reports of serious adverse transfusion reactions between 1997 and 2007. Transfus Med 2009; 19: 340-349.
20. Andreu G, Caldani C, Morel P,. Reduction of septic transfusion reactions related to bacteria contamination without implementing bacteria detection. ISBT Sci Ser 2008; 3: 124-132.
21. Bruneau C, Perez P, Chassaigne M, et-al. Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion 2001; 41: 74-81.
22. de Korte D, Marcelis JH, Verhoeven AJ, et-al. Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang 2002; 83: 13-16.
23. McDonald GP, Roy A, Mahajan P, et-al. Relative values of the intervention of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004; 86: 178-182.
24. Décision du 6 novembre 2006 définissant les principes de bonnes pratiques prévus à l'article L.1223-3 du code de la sante publique. J O Repub Fr 2006 Nov 10: text 24/131.
25. Fang CT, Chambers LA, Kennedy J, et-al. Detection of bacterial contamination in apheresis products: American Red Cross experience, 2004. Transfusion 2005; 45: 1845-1852.
26. Walther-Wenke G, Schrezenmeier H, Deitenbeck R, et-al. Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up. Ann Hematol 2010; 89: 83-91.
27. Bolton-Maggs PH, Cohen H,. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 2013; 163: 303-314.
28. Jacobs MR, Good CE, Lazarus HM, et-al. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008; 46: 1214-1220.
29. Kuehnert MJ, Roth VR, Haley NR, et-al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41: 1493-1499.
30. Williamson IM, Lowe S, Love EM, et-al. Serious hazards of transfusion (SHOT) initiative analysis of the first two annual reports. BMJ 1999; 319: 16-19.
31. Benjamin RJ, Kline L, Dy BA, et-al. Bacterial contamination of whole blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion 2008; 48: 2348-2355.
32. Goldman M, Delage G, Beauregard P, et-al. A fatal case of transfusion-transmitted Staphylococcus epidermidis sepsis. Transfusion 2001; 41: 1075-1076.
33. de Korte D, Curvers J, de Kort WL, et-al. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006; 46: 476-485.
34. Schrezenmeier H, Walther-Wenke G, Müller TH, et-al. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007; 47: 644-652.
35. Kleinman SH, Kamel HT, Harpool DR, et-al. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 2006; 46: 1787-1794.
36. Yomtovian RA, Palavecino EL, Dysktra AH, et-al. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion 2006; 46: 719-730.
37. Högman CF, Gong J, Eriksson L, et-al. White cells protect donor blood against bacterial contamination. Transfusion 1991; 31: 620-626.
38. Wenz B, Ciavarella D, Freundlich L,. Effect of prestorage white cell reduction on bacterial growth in platelet concentrates. Transfusion 1993; 33: 520-523.
39. Siblini L, Lafeuillade B, Ros A, et-al. Reduction of Yersinia enterocolitica load in deliberately inoculated blood: the effects of blood prestorage temperature and WBC filtration. Transfusion 2002; 42: 422-427.
40. Siblini L, Lafeuillade B, Ros A, et-al. Influence of blood prestorage conditions and white blood cell filtration on the bacterial load of blood deliberately inoculated with Gram-positive and Gram-negative pathogens. Vox Sang 2004; 87: 241-249.
41. Mohr H, Bayer A, Gravemann U, et-al. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates. Transfusion 2006; 46: 949-955.
42. Buchholz DH, AuBuchon JP, Snyder EL, et-al. Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion 1994; 34: 852-857.
43. Holden F, Foley M, Devin G, et-al. Coagulase-negative staphylococcal contamination of whole blood and its components: the effects of WBC reduction. Transfusion 2000; 40: 1508-1513.
44. McDonald CP, Hartley S, Orchard K, et-al. Fatal Clostridium perfringens sepsis from a pooled platelet transfusion. Transfus Med 1998; 8: 19-22.
45. Blajchman MA, Sarwal S, Loeb M,. A second example of a transfusion-associated septic reaction associated with Clostridium perfringens. Transfusion 2001; 41: 427-428.
46. Serious Hazards of Transfusion Steering Committee. Serious hazards of transfusion: annual report 2000-2001. July 2003 [cited 2014 Sep 14]. Available from http://www.shotuk.org/wp-content/uploads/2010/03/SHOT-Report-01-02.pdf
47. te Boekhorst PA, Beckers EA, Vos MC, et-al. Clinical significance of bacteriologic screening in platelet concentrates. Transfusion 2005; 45: 514-519.
48. Högman CF, Fritz H, Sandberg L,. Posttransfusion Serratia marcescens septicemia (editorial). Transfusion 1993; 33: 189-191.
49. Eder AF, Kennedy JM, Dy BA, et-al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007; 47: 1134-1142.
50. Benjamin RJ, Dy B, Perez J, et-al. Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results. Vox Sang 2014; 106: 23-30.
51. McDonald CP,. Transfusion risk reduction: testing for bacteria. ISBT Sci Ser 2013; 8: 73-79.
52. Schmidt M, Seifried E,. Current status of bacterial detection in blood components-successes and challenges. ISBT Sci Ser 2012; 7: 207-213.
53. Jenkins C, Ramírez-Arcos S, Goldman M, et-al. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; 51: 2555-2565.
54. Prowse CV,. Component pathogen inactivation: a critical review. Vox Sang 2013; 104: 183-199.
55. Cid J, Escolar G, Lozano M,. Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials. Vox Sang 2012; 103: 322-333.
56. Vamvaka EC,. Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system. Vox Sang 2012; 102: 302-316.